ProShare Advisors LLC Raises Stock Holdings in Aflac Incorporated $AFL

ProShare Advisors LLC lifted its stake in shares of Aflac Incorporated (NYSE:AFL) by 10.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,731,482 shares of the financial services provider’s stock after acquiring an additional 163,791 shares during the period. ProShare Advisors LLC owned 0.32% of Aflac worth $193,407,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Personalized Indexing Management LLC raised its holdings in Aflac by 11.9% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 93,449 shares of the financial services provider’s stock valued at $9,856,000 after buying an additional 9,907 shares during the period. Nordea Investment Management AB increased its position in shares of Aflac by 3.8% in the third quarter. Nordea Investment Management AB now owns 1,768,705 shares of the financial services provider’s stock worth $196,662,000 after acquiring an additional 65,308 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Aflac by 12.2% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 90,976 shares of the financial services provider’s stock valued at $10,162,000 after acquiring an additional 9,878 shares during the period. Rakuten Investment Management Inc. acquired a new position in shares of Aflac during the 3rd quarter valued at $1,117,000. Finally, Oregon Public Employees Retirement Fund boosted its position in Aflac by 31.0% during the 3rd quarter. Oregon Public Employees Retirement Fund now owns 55,022 shares of the financial services provider’s stock worth $6,146,000 after purchasing an additional 13,017 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on AFL shares. Barclays set a $101.00 price objective on Aflac and gave the company an “underweight” rating in a research report on Thursday, January 8th. Evercore raised their target price on Aflac from $110.00 to $111.00 and gave the company an “underperform” rating in a report on Friday, November 7th. Wells Fargo & Company boosted their price target on Aflac from $107.00 to $109.00 and gave the stock an “equal weight” rating in a research report on Friday, November 7th. TD Cowen reaffirmed a “hold” rating on shares of Aflac in a research report on Monday, December 22nd. Finally, Mizuho initiated coverage on shares of Aflac in a research report on Tuesday, December 16th. They set an “underperform” rating and a $104.00 target price on the stock. Three analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $110.64.

Insider Buying and Selling

In related news, EVP Audrey B. Tillman sold 15,862 shares of the business’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $112.00, for a total value of $1,776,544.00. Following the completion of the sale, the executive vice president directly owned 230,688 shares of the company’s stock, valued at $25,837,056. The trade was a 6.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Joseph L. Moskowitz sold 786 shares of the stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $113.75, for a total value of $89,407.50. Following the transaction, the director directly owned 24,829 shares in the company, valued at approximately $2,824,298.75. This represents a 3.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 29,044 shares of company stock worth $3,241,981. Corporate insiders own 0.80% of the company’s stock.

Key Aflac News

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Revenue beat estimates—Aflac reported Q4 revenue above consensus, reflecting strong top-line performance that offsets some earnings weakness. AFLAC ($AFL) Releases Q4 2025 Earnings
• Positive Sentiment: Company is boosting shareholder returns—Aflac’s quarter included actions to increase returns to shareholders, which supports the dividend/repurchase narrative. Aflac Reports Mixed Q4 Results, Boosts Shareholder Returns
• Positive Sentiment: Management set 2026 benefit-ratio targets and signaled continued capital deployment—this implies confidence in margin trends (especially in Japan) and potential for ongoing buybacks/dividends. Aflac outlines 2026 benefit ratio targets and signals continued strong capital deployment
• Neutral Sentiment: Full earnings materials available—investors have access to the earnings presentation and detailed call transcript to parse reserves, investment income and segment trends. Aflac Incorporated 2025 Q4 – Results – Earnings Call Presentation
• Negative Sentiment: EPS missed consensus—Q4 GAAP EPS came in below estimates ($1.57 vs. ~ $1.69–$1.71), pressured by lower investment income and higher costs, which is the immediate driver of downward price pressure. Aflac Q4 Earnings Miss Estimates on Lower Investment Income
• Negative Sentiment: Cybersecurity fallout and management commentary raised investor concerns—coverage highlights how post-earnings commentary and cyber-related issues could influence sentiment and near-term stock performance. How Investors May Respond To Aflac (AFL) Earnings Amid Cybersecurity Fallout And Management Commentary
• Negative Sentiment: Analyst mix and insider selling—several firms have low or underweight ratings and recent insider sales plus a median analyst target below the current price add downward pressure. AFLAC ($AFL) Releases Q4 2025 Earnings

Aflac Stock Performance

Aflac stock opened at $117.19 on Monday. Aflac Incorporated has a 52 week low of $96.95 and a 52 week high of $119.32. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.29. The stock has a market cap of $61.42 billion, a P/E ratio of 17.03, a price-to-earnings-growth ratio of 3.83 and a beta of 0.67. The stock has a 50 day moving average of $110.11 and a 200-day moving average of $108.73.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.12). The company had revenue of $4.87 billion during the quarter, compared to analyst estimates of $4.45 billion. Aflac had a net margin of 21.24% and a return on equity of 14.35%. The company’s revenue was down 9.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.57 earnings per share. On average, analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Wednesday, February 18th will be paid a $0.61 dividend. This represents a $2.44 dividend on an annualized basis and a yield of 2.1%. This is a positive change from Aflac’s previous quarterly dividend of $0.58. The ex-dividend date is Wednesday, February 18th. Aflac’s payout ratio is 33.72%.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.